About 77,400 results
Open links in new tab
Patritumab Deruxtecan Demonstrated Statistically Significant
Patritumab Deruxtecan Demonstrated Statistically Significant ...
Patritumab Deruxtecan Meets PFS End Point in Pretreated EGFR …
Patritumab deruxtecan extends PFS vs. chemotherapy in …
Patritumab Deruxtecan Granted Priority Review in the U.S. for
Patritumab Deruxtecan BLA Submission Receives Complete …
Patritumab Deruxtecan Demonstrated Clinically Meaningful and …
Patritumab Deruxtecan Demonstrates a Manageable Safety …
Patritumab Deruxtecan Granted U.S. FDA Breakthrough Therapy …
Patritumab Deruxtecan Active in HER3-Expressing ... - ASCO Daily News
- Some results have been removed